Molecular PCR Testing
Real-time PCR kits & instruments KogeneBiotech for SARS-nCoV-2 detection
- PowerChek™ 2019-nCoV kit, first validated kit on the market
- PowerAmp96™ Real-time PCR instrument, optimized for PowerChek™ kits
Nucleic acid extractors & kits
Tanbead
Affordabe nucleic acid extractors and kits for COVID-19 Real-time PCR detection
Video TANBead Maelstrom 9600
Qnostics third party RT-PCR controls
Randox
In response to the current coronavirus outbreak, Randox Qnostics, a world leading manufacturer of QC solutions for molecular infectious disease testing has developed a SARS-CoV-2 control designed for use alongside molecular assays used in the testing of COVID-19.
Download more information
Automated nucleic acid extraction Beckman Coulter - Biomek i5
Nucleic Acid Solution for automated nucleic acid extraction.
This platform combines industry leading automation technology and proprietary SPRI-based chemistry to deliver optimized purification methods to help you in your COVID-19 workflow.
Automated nucleic acid extraction Beckman - RNAdvance Viral or Viral XP
Extract high-quality RNA from Saliva or Swab Transport Media samples using SPRI paramagnetic bead-based technology. Our viral RNA extraction kits are available for your unique input sample types and collection devices. RNAdvance Viral XP offers higher throughput capabilities and the RNAdvance Viral kit is optimal for extracting from a variety of challenging sample inputs.
Lab Automation & high throughput
Beckman Liquid handlers for reaction setup
Genetic characterization or analysis of viruses using PCR, qPCR, RT-PCR, or sequencing can be set up with automated liquid handlers from Beckman Coulter. Both the Echo 525 and Biomek i-Series enable you data traceability and compliance to achieve higher throughput in your experiments
Serological Testing : Rapid antibody tests
Rapid serological testing Covid-19
Rapid antibody IgM– IgG test
Healgen
This IgM-IgG combined antibody test is used for the rapid qualitative and differential detection of IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro. These proteins indicate that a person’s immune system has responded to infection with the COVID-19 virus. By using biomarkers from the body’s immune response to SARS-CoV-2 virus instead of looking for the virus itself, the test can help determine if a person has been infected with SARS-CoV-2 virus even after the virus is no longer present. The sensitivity of IgM test is 87,9% and specificity is 100% compared to the RT-PCR. The sensitivity of IgG test is 97,2% during the convalescence period, and specificity is 100%.
REQUIRES NO INSTRUMENTATION PROVIDES RESULTS IN 10 MINUTES.
*(CE-IVD & FDA EUA Certified)
Learn more
Automated serological test kits on immunoassays analyzers
Beckman SARS-cov2 IgG antibody test
- SARS- CoV2 IgG Assay - Beckman Coulter - General Brochure
- SARS- CoV2 IgG Assay - Beckman Coulter : need for efficiency SARS-CoV2
- SARS- CoV2 IgG Assay - Benefits of a stand alone IgG assays vs.a combined IgM/IgG Assay
- SARS- CoV2 IgG Assay - The medical value of Spike Protein
Automated serological test kits on immunoassays analyzers
Beckman Coulter Assay
In general virus infection behavior, an IgM assay will give information about current or recent infection; while IgG will, in addition, also give information about a more sustainable immune response. These two pieces of the infection story blur together when the patient takes a combined, or total IgM and IgG test. Because seroconversion is such a highly individualized journey, separate SARS-CoV-2 IgM and IgG tests can provide greater insight into where the patient is at in their infection timeline
Virus Detection : Rapid Antigen tests
OrientGene®/HEALGEN® COVID-19 Rapid Antigen Test
The Coronavirus Ag Rapid Test Cassette (Swab) is an in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal (NP) swab specimens directly or after the swabs have been added to viral transport media from individuals who are suspected of COVID-19 by their healthcare provider. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infections.
Learn more
OrientGene®/HEALGEN® COVID-19 Rapid Antigen Test
Now also validated for nasal swab
Disease Monitoring
Covid-19 patient monitoring with ivd tests
BECKMAN chemistry and immunoassay.
To assess the severity and progression of COVID-19, in vitro diagnostic (IVD) testing is critical. IVD tests can also help monitor and adjust treatment.
Beckman Coulter is proud to offer a "Menu That Matters" through their automated chemistry and immunoassay solutions. The assays will be designed for use on any of its high- throughput Access family of immunoassay systems, including the Access 2 and DxI series installed globally.
Article "Serum Amyloid A (SAA), for Turbidimetry"
Article "Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis"
Learn more
Immune status monitoring
of a patient
Beckman Flow Cytometry AQUIOS
Aquios of Beckman-Coulter is the first fully automatic flow cytometer from the primary tube to the final result.
Fast: The sample is automatically prepared and analyzed. The results is ready after about 20 minutes.
Safe: The system is closed and automatic. The risk of contamination of the user is very low.
Easy to use: A simple training is sufficient to use the system. There is no need for extensive knowledge of the flow cytometer.
Aquios is the safest solution to monitor the immune status of the B, T lymphocytes, the NK and the monocytes.
Video : The Aquios Advantage
Clinical Testing
Sigma - Clinical centrifuges
Beckman Coulter - Flow Cytometry
Study of the immunity mechanisms with adaptive flow cytometer BECKMAN COULTER CytoFlex and a ready to use cocktail DURACLONE. VIDEO
Article: Cossarizza, A., De Biasi, S., Guaraldi, G., Girardis, M., Mussini, C. and (2020), SARS‐CoV‐2, the Virus that Causes COVID‐19: Cytometry and the New Challenge for Global Health. Cytometry, 97: 340-343. doi:10.1002/cyto.a.24002